BioMonde UK is a pioneering company in the health care and manufacturing industries, with a focus on Larval Therapy wound care products. The company's commitment to R&D, innovation, and education has positioned it as a global leader in wound care, transforming patient lives and making healing possible. Founded in 2004, BioMonde operates from its headquarters in the United Kingdom and boasts state-of-the-art production facilities in the UK and Germany, servicing over 10 countries daily. Despite the lack of publicly disclosed recent investments and investors, BioMonde's impactful presence in wound debridement solidifies its position as a key player in advancing medical solutions.
There is no investment information
No recent news or press coverage available for BioMonde UK.